The Endpoint Bubble: Why Clinical Trials Are Drowning in Measurements That Don’t Matter | Cromos Pharma
The Endpoint Bubble: Why Clinical Trials Are Drowning in Measurements That Don’t Matter Why clinical trials collect too many endpoints — and how endpoint bloat obscures study goals instead of improving drug development insights. Read more
Five trends from the ASCO Annual Meeting 2026 | Cromos Pharma
ASCO 2026: Five Trends That Caught My Attention By Vlad Bogin, MD, FACP  CEO, Cromos Pharma  ASCO 2026 delivered thousands of abstracts and countless data points. Beyond individual studies, several broader trends stood out to me as particularly important for the future of oncology and clinical development. Precision Oncology Is Becoming More Precise The industry is moving beyond identifying who should receive a treatment and toward determining who may Read more
Clinical Research Focus. 53rd Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of May 2026. Read more
FSP Model in Clinical Trials — Everything Sponsors Need to Know
FSP Clinical Research: Everything Sponsors Need to Know The global clinical outsourcing landscape is evolving rapidly. As trials become more complex, decentralized, and data-intensive, biopharma companies are rethinking how they build operational capacity. Across the industry, there is a clear shift toward more flexible, transparent, and scalable outsourcing structures—driven by the rising adoption of Functional Service Provider (FSP) partnerships. FSP models enable sponsors Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us